Skip to main content
. 2020 May 25;2020:4910595. doi: 10.1155/2020/4910595

Figure 3.

Figure 3

Expression of IL-17A, IL-17F, IL-17RA, and IL-17RC in prostate cancer divided into groups using the Gleason score and benign prostatic hyperplasia (BPH) (20x magnification).